HLNHaleon plc
$9.31+3.0% 1Y
$9.31
$8.6152 weeks$11.12
HLN as reported
Haleon plc reported £11.0B of revenue over the trailing twelve months, −1.8% on the year before. 10 reported series are charted on this page, each one as filed.
£11.0B
Revenue, trailing twelve months · to FY2025 · −1.8% against the twelve months before
- Net income
- £1.67B
Net income · +16% year on year · trailing twelve months to FY2025
- Free cash flow
- £2.31B
Free cash flow · +13% year on year · trailing twelve months to FY2025
- Operating margin
- 22%
Operating margin · trailing twelve months to FY2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | £11.0B | −1.8% | FY2025 |
| Net income | £1.67B | +16% | FY2025 |
| EPS | £0.19 | +18% | FY2025 |
| Gross margin | 64% | n/a | FY2025 |
| Operating margin | 22% | n/a | FY2025 |
| Net margin | 15% | n/a | FY2025 |
| ROE | 10% | n/a | FY2025 |
| ROA | 5.1% | n/a | FY2025 |
| ROIC | 8.2% | n/a | FY2025 |
| Free cash flow | £2.31B | +13% | FY2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Haleon plc (HLN) · Revenue and profitRevenue and profitHaleon plc (HLN)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Drug Manufacturers, Specialty & Generic
Ranks #12 of 41 by RyuScore